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Background: Leishmaniasis is a major public health
problem causing significant morbidity and mortality
in Africa, Asia and Latin America. It presents mainly
in three clinical forms, of which visceral leishmania-
sis (VL) is the most severe form. Recent outbreaks of
VL in India and the epidemic of human immunode-
ficiency virus (HIV) make VL a re-emerging problem
in India1.  Outbreaks and epidemics of leishmaniasis
have also been associated with urban development,
deforestation, environmental changes and population
migrations. Individual risk factors such as HIV, mal-
nutrition, genetic factors, etc. are also responsible for
epidemiological diversity of leishmaniasis2. Approxi-
mately, a total 500,000 VL cases occur annually
worldwide of which  more than 23,000 cases are from
India. The present foci of VL in India are Bihar, West
Bengal, Uttar Pradesh and Jharkhand3. Sporadic
cases have also been reported from Gujarat (west
India)4, Tamil Nadu and Kerala (south India) and sub-
Himalayan parts of north India including Uttar
Pradesh, Himachal Pradesh and Jammu and Kash-
mir5. To the best of our knowledge and available lit-
erature, after 1986 no case of VL has been reported
from Gujarat so far. It is a common belief that west-
ern India has become VL free zone but this case study
shows that the population of Gujarat state is again at
risk of kala-azar after about 20 years.
Case report: A 25 year-old male from Delhi, was re-
cently been shifted to Anand district of Gujarat and
started having fever, occasional chills and rigors
within five months of his stay in Gujarat, and did not
respond to standard treatment. Initially, for his febrile
illness, he was investigated and treated by local phy-
sician for malaria (peripheral blood smear examina-
tion and Plasmodium falciparum and P.  vivax anti-
gen detection) and typhoid fever (Widal and
TyphiDot test) but was found to be negative. He was
put on antipyretics but in the mean time he also de-
veloped anaemia (haemoglobin 7.5 g/dl) and hepato-
splenomegaly. However, more details of investiga-
tions were not available with the patient. When no
conclusive diagnosis could be made locally, he was
referred to the All India Institute of Medical Sciences
(AIIMS), New Delhi, where he was again investi-
gated thoroughly for malaria and other causes of fe-
ver of unknown origin including blood culture, chest
X-ray and abdominal ultrasonography; and he was
also investigated for Hepatitis B virus surface antigen
(HBsAg), Hepatitis C virus (HCV) and HIV but was
found to be negative for all. His family history re-
vealed that neither his family members nor the patient
visited any known endemic area for kala-azar except
the patient had stayed in Gujarat for five months. He
neither had any prolonged illness in the past nor did
he receive blood transfusion. On physical examina-
tion he had mild fever, anaemia and hepatosplenom-
egaly which was further confirmed by abdominal ul-
trasonography. His routine serum biochemistry and
haematology investigations showed total protein of
11 g/dl and albumin/globulin ratio 0.43. His platelet
count was 60,000/mm3, haemoglobin level 7 g/dl,
TLC 1,500/mm3, RBC count 3.73 × 106/mm3, WBC
count 1.60 × 103/mm3 with differential count of 59%
neutrophils, 1% eosinophils, 2% monocytes and 38%
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His splenic aspirate was examined by Giemsa stain-
ing that was found positive for Leishman-Donovan
(LD) bodies like structures. His bone marrow aspirate
was cellular with signs of reactive marrow. His serum
samples were tested by aldehyde test, anti-rK39 dip-
stick test (InsureTM, In-Bios Int., USA), rKE16 latex
agglutination test, and anti-rKE16 spot test (Signal
KATM, Span Diagnostics Limited, India). The latter
is a novel recombinant antigen recently prepared
from Leishmania donovani strain KE16 (MHOM/IN/
1998/KE16)6. The aldehyde test, rKE16 latex agglu-
tination test, Signal KA spot test (rKE16) and In-Bios
dipstick test (rK39) were found to be strongly posi-
tive. Using rK39 and rKE16 antigens, serum of the
patient was also end point titrated for anti-rK39 and
anti-rKE16 antibodies by ELISA7, which revealed
strong antibody reaction with titers of 1:102400 and
1:409600, respectively. The anti-rKE16 antibody
avidity examination was also done to elucidate the
phase of the infection occurred. The rKE16 IgG an-
tibody avidity was found 79.23%, which indicated
that the infection occurred between 6 and 8 months7.
When diagnosis of kala-azar was established, the pa-
tient was treated with a full course of amphotericine B
(50 mg/day) for 10 days. The patient started improv-
ing clinically within three days and at the end of the
treatment his platelet count increased up to 1,20,000/
mm3, TLC up to 2,900/mm3 with normocytic and nor-
mochromic RBC picture and haemoglobin level rose
to 9.5 g/dl. He was last followed-up after six months
of treatment and found completely asymptomatic and
all laboratory parameters were within normal limits.
The visceral form of leishmaniasis is endemic in east-
ern states of India. However, in last quarter of the
twentieth century migration of disease was noticed
and new foci of this disease were reported from pre-
viously non-endemic regions8. No case of VL has
been reported from Gujarat since 1986, eventhough,
sporadic cases have been reported from this area pre-
viously. Though, it is difficult to explain that how he
acquired infection. The patient neither travelled any
known endemic area for kala-azar except Gujarat, nor
did he has any history of blood transfusion and injec-
tion sharing, as possible source of infection.
Anand district, in the Gujarat state lies at latitude
22°14´N and longitude 72°46´E. The nature of the
soil in this district is alluvial and black rocky. It also
represents great river basins such as Narmada and
Sabarmati. The climate of the area is hot and humid
which is favourable for the incidence of kala-azar9.
This case gives an opportunity to investigate whether
the parasite has re-established in this part of India or
it was an accidental case. It is possible that during the
travel he acquired the infection. It is also possible that
due to repeated spray of malathion during 1980–86
under the National Malaria Eradication Programme,
which might have either eliminated the sandfly spp
from the area or driven the residual population to
some obscure outdoor microhabitat10 and after a long
time sandfly is re-habitating in the area. We cannot
rule out the possibility that this leishmania strain is
less virulent and might be circulating in some animal
reservoirs. It is likely that the disease has been re-in-
troduced in the state and is spread by some local spe-
cies of sandfly. In either case the present case report
highlights geographic changes leading to ecological
disturbance with a possible spread of leishmaniasis
in India with implications for its control as a public
health problem. 
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